Medline Business Summary

Medline Inc. (MDLN) utilizes a vertically integrated business model to dominate the medical-surgical supply chain, generating revenue through high-volume product transactions and long-term prime vendor service agreements. The company’s revenue streams are divided into two core segments: Medline Brand, which manufactures over 190,000 proprietary SKUs across 33 global facilities, and Supply Chain Solutions, which provides end-to-end logistics, inventory analytics, and distribution for both Medline-branded and third-party medical products. This dual-revenue approach allows Medline to capture manufacturing margins that pure-play distributors cannot, effectively positioning the firm as a more profitable, integrated alternative to industry giants like McKesson, Cardinal Health, Owens & Minor, and Medtronic. The company was founded in 1966 by brothers Jim and Jon Mills, building on a family legacy in medical garments dating back to 1910. Current leadership is headed by CEO Jim Boyle, a Texas A&M alumnus who ascended through the company’s sales ranks over three decades, and President Jim Pigott. Key executives include CFO Mike Drazin, previously of Illinois Tool Works, and CIO Marshall Lancaster, who oversees the firm’s digital infrastructure and AI-driven supply chain tools. Following its landmark $6.26 billion IPO in December 2025, Medline’s board is chaired by Charlie Mills and includes significant representation from its private equity backers—Blackstone, Carlyle, and Hellman & Friedman—who orchestrated the company’s 2021 leveraged buyout and maintain substantial post-IPO equity.